Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 30, 2013 - Issue 5
Submit an article Journal homepage
175
Views
0
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR

Response to the Letter: Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Gaucher Disease

Sawa ItoHematology Branch, NHLBI, National Institutes of Health, Bethesda, USACorrespondence[email protected]
&
A. John BarrettHematology Branch, NHLBI, National Institutes of Health, Bethesda, USA
Pages 462-463 | Received 04 Apr 2013, Accepted 04 Apr 2013, Published online: 12 Jul 2013

REFERENCES

  • Ito S, Barrett AJ. Gaucher's disease–a reappraisal of hematopoietic stem cell transplantation. Pediatr Hematol Oncol. 2013;30(2):61–70.
  • Treiber A, Morand O, Clozel M. The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor miglustat in the rat. Xenobiotica. 2007;37(3):298–314.
  • Schiffmann R, Fitzgibbon EJ, Harris C, Randomized, controlled trial of miglustat in Gaucher's disease type 3. Ann Neurol. 2008;64(5):514–522.
  • Zimran A. How I treat Gaucher disease. Blood. 2011;118(6):1463–1471.
  • Shayman JA. Eliglustat tartrate: glucosylceramide synthase inhibitor treatment of type 1 Gaucher disease. Drugs Future. 2010;35(8):613–620.
  • Hsieh MM, Kang EM, Fitzhugh CD, Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med. 2009;361(24):2309–2317.
  • Hsieh MM, Fitzhugh CD, Tisdale JF. Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now. Blood. 2011;118(5):1197–1207.
  • Kraoua I, Sedel F, Caillaud C, A French experience of type 3 Gaucher disease: phenotypic diversity and neurological outcome of 10 patients. Brain Dev. 2011;33(2):131–139.
  • Staba SL, Escolar ML, Poe M, Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med. 2004;350(19):1960–1969.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.